Total Funding
23
67
Total FundingEquity Crowdfunding raised
Growth Score
-30 pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
165456
Cern Corporation develops a light-based device for bacterial vaginosis and vaginal yeast infections, with sensors and telemedicine.
- Gregg Klang: CEO, Founder & Inventor
About the Company
Cern Corporation develops The Cern Device, a light-based microbicidal therapy intended for the treatment of bacterial vaginosis and vaginal yeast infections. The company designs a prescription device and related sensors that enable at‑home use with clinician oversight via telemedicine workflows. Capabilities include programmed light dosing, data
capture, and digital guidance for patients and prescribers. Cern Corporation supports clinical research and posts study information, and holds granted utility patents related to the platform. Educational resources for healthcare professionals and patients accompany the device program.
